LINFA








Articles

Hits
Linfa
News
Projects
Reports

Links
Sitemap
Underbreath

Italiano

 

Laboratory for Innovative Antimetastasis Drugs





 


LINFA - Within the Callerio Foundation, a worldwide reference point for researchers who investigate anti-metastatic ruthenium-based drugs and their pharmacological properties.
LINFA has the main task of promoting the research on pharmacological treatment of solid tumor metastases based on ruthenium complexes, and originates from the experience cumulated by researching the properties of a new drug within this family.
Callerio Foundation and anticancer metal-drug development
Updating of published results
Hits on anticancer metal-based compound discovery

ANTICANCER METALS OF POSTGENOMIC ERA (MADE) (2003-2007)

LINFA UPDATINGS (october 2002):

CHANGES OF ACTIVITY
ORGANISATION OF EXPERIMENTAL TESTING

PROPOSED SEQUENCE FOR THE EXPERIMENTAL TEST
WE HAVE THE EXPERIENCE, THE EQUIPMENT AND THE CONNECTIONS REQUIRED TO SUPPORT SUCH A RESEARCH IN ALL ITS PHASES.
IF YOU THINK THAT YOUR WORK MIGHT BENEFIT FROM A COOPERATION WITH LINFA, GET IN CONTACT WITH US

Callerio Foundation via Fleming 31 - 34127 Trieste ITALY ph/fax +39 040 569933 - mail@callerio.org